ARTICLE | Company News
Biovation, Micromet in proteins agreement
August 28, 2001 7:00 AM UTC
Biovation (Aberdeen, U.K.), a Merck KGaA company, will use its DeImmunisation technology on therapeutic proteins designed by Micromet (Martinsried, Germany). Biovation is eligible for research revenue...